Pathogenicity and drug resistance of animal streptococci responsible for human infections

J Med Microbiol. 2021 Mar;70(3). doi: 10.1099/jmm.0.001339. Epub 2021 Mar 22.

Abstract

Bacteria of the genus Streptococcus, earlier considered typically animal, currently have also been causing infections in humans. It is necessary to make clinicians aware of the emergence of new species that may cause the development of human diseases. There is an increasing frequency of isolation of streptococci such as S. suis, S. dysgalactiae, S. iniae and S. equi from people. Isolation of Streptococcus bovis/Streptococcus equinus complex bacteria has also been reported. The streptococcal species described in this review are gaining new properties and virulence factors by which they can thrive in new environments. It shows the potential of these bacteria to changes in the genome and the settlement of new hosts. Information is presented on clinical cases that concern streptococcus species belonging to the groups Bovis, Pyogenic and Suis. We also present the antibiotic resistance profiles of these bacteria. The emerging resistance to β-lactams has been reported. In this review, the classification, clinical characteristics and antibiotic resistance of groups and species of streptococci considered as animal pathogens are summarized.

Keywords: Streptococcus; bacterial drug resistance; streptococcal infections; virulence; zoonoses.

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Drug Resistance, Bacterial*
  • Humans
  • Streptococcal Infections / drug therapy
  • Streptococcal Infections / microbiology*
  • Streptococcal Infections / transmission
  • Streptococcus / classification
  • Streptococcus / drug effects
  • Streptococcus / pathogenicity*
  • Streptococcus / physiology*
  • Virulence
  • Zoonoses / drug therapy
  • Zoonoses / microbiology*
  • Zoonoses / transmission

Substances

  • Anti-Bacterial Agents